Bioink: a 3D-bioprinting tool for anticancer drug discovery and cancer management

Drug Discov Today. 2021 Jul;26(7):1574-1590. doi: 10.1016/j.drudis.2021.03.010. Epub 2021 Mar 16.

Abstract

'Bioinks' are important tools for the fabrication of artificial living-tissue constructs that are able to mimic all properties of native tissues via 3D bioprinting technologies. Bioinks are most commonly made by incorporating live cells of interest within a natural or synthetic biocompatible polymeric matrix. In oncology research, the ability to recreate a tumor microenvironment (TME) using by 3D bioprinting constitutes a promising approach for drug development, screening, and in vitro cancer modeling. Here, we review the different types of bioink used for 3D bioprinting, with a focus on its application in cancer management. In addition, we consider the fabrication of bioink using customized materials/cells and their properties in the field of cancer drug discovery.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Bioprinting*
  • Drug Discovery*
  • Humans
  • Neoplasms / drug therapy*
  • Printing, Three-Dimensional*

Substances

  • Antineoplastic Agents